北米の脱毛症 (ヘアロス)治療市場

出版：Inkwood Research

NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2021-2028

–

このレポートへお問合せ　　　レポート目次

Inkwood Research「NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2021-2028」は北米の脱毛症 (ヘアロス)治療市場を分析・予測した市場調査レポートです。

KEY FINDINGS
The North America alopecia (hair loss) treatment market is evaluated to record a CAGR of 4.40% over the forecasting period of 2021 to 2028. Key factors such as the growing emphasis on aesthetics, the well-established presence of pharmaceutical firms working towards the effective treatment of alopecia, the rising disposable income, and the increased consumption of alcohol predominantly fuel the regional market’s growth.
MARKET INSIGHTS
The North America alopecia (hair loss) treatment market growth assessment entails the evaluation of Canada and the United States. Canada houses multiple non-profit organizations as well as hair specialist salons endeavoring towards treating alopecia. In this regard, Canada’s charitable organization named, Canadian Alopecia Areata Foundation (CANAAF) is mainly dedicated to the condition’s treatment. It predominantly extends support to individuals diagnosed with alopecia areata in Canada. The organization also promotes education and awareness regarding such autoimmune diseases and raises substantial funds for research, as well.
Conversely, Canada has a non-profit organization committed to educating, advocating, and supporting citizens living with alopecia conditions, skin diseases, and traumas. The country also witnesses a considerable rise in smoking and alcohol consumption, resulting in increased hair loss complications among Canadian adults. As a result, these factors play an essential role in facilitating the North America alopecia (hair loss) treatment market growth over the estimated years.
COMPETITIVE INSIGHTS
Some of the major companies operating in the market are Johnson & Johnson Inc, Concert Pharmaceuticals, Merk & Co Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISE IN AUTOIMMUNE DISEASES
3.1.2. HIGH CONSUMPTION OF ALCOHOL AND TOBACCO
3.1.3. UNHEALTHY DIETARY HABITS
3.1.4. STRESS AND CHANGING LIFESTYLES
3.2. KEY RESTRAINTS
3.2.1. RISK OF INFECTIONS OR SIDE EFFECTS
3.2.2. HIGH COSTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON ALOPECIA (HAIR LOSS) TREATMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY GENDER
5.1. FEMALE
5.2. MALE
6. MARKET BY INDICATIONS
6.1. ANDROGENIC ALOPECIA
6.2. ALOPECIA AREATA
6.3. ALOPECIA TOTALIS
6.4. OTHER INDICATIONS
7. MARKET BY DISTRIBUTION CHANNELS
7.1. DRUG STORES & RETAIL PHARMACIES
7.2. HOSPITAL PHARMACIES
7.3. ONLINE PHARMACIES
8. MARKET BY TREATMENT
8.1. TOPICAL
8.1.1. MINOXIDIL
8.1.2. SHAMPOOS
8.2. ORAL
8.2.1. FINASTERIDE
8.2.2. OTHER ORAL HAIR LOSS TREATMENT
8.3. OTHER TREATMENT TYPES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. KEY GROWTH ENABLERS
9.1.3. KEY CHALLENGES
9.1.4. KEY PLAYERS
9.1.5. COUNTRY ANALYSIS
9.1.5.1. UNITED STATES
9.1.5.2. CANADA
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
10.2.1. ACLARIS THERAPEUTICS
10.2.2. CELLMID
10.2.3. CIPLA LTD
10.2.4. CONCERT PHARMACEUTICALS
10.2.5. DAIICHI SANKYO
10.2.6. DR. REDDY’S LABORATORIES
10.2.7. JOHNSON AND JOHNSON
10.2.8. LEXINGTON INTERNATIONAL
10.2.9. MERK & CO INC
10.2.10. SHISEIDO COMPANY LIMITED
10.2.11. SUN PHARMACEUTICAL INDUSTRIES LTD
10.2.12. TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
10.2.13. TEVA PHARMACEUTICALS INDUSTRIES LTD
10.2.14. THE HIMALAYA DRUG COMPANY
10.2.15. TRANSITION HAIR PVT LTD

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT ? ALOPECIA (HAIR LOSS) TREATMENT MARKET
TABLE 2: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA L ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: LEADING PLAYERS OPERATING IN NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

List of Figures

LIST OF FIGURES
FIGURE 1: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES 2019
FIGURE 2: KEY MARKET TRENDS
FIGURE 3: PORTER’S FIVE FORCES ANALYSIS
FIGURE 4: OPPORTUNITY MATRIX
FIGURE 5: VENDOR LANDSCAPE
FIGURE 6: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
FIGURE 7: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020
FIGURE 10: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020
FIGURE 15: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020
FIGURE 19: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020
FIGURE 21: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020
FIGURE 25: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
FIGURE 26: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 27: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 28: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 29: UNITED STATES ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: CANADA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

お問合せフォーム